| Industry perceptions of barriers to commercialization of regenerative medicine products in the UK. | |
| | |
MedLine Citation:
|
PMID: 19580404 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: Regenerative medicine is an emerging field with the potential to provide widespread improvement in healthcare and patient wellbeing via the delivery of therapies that can restore, regenerate or repair damaged tissue. As an industry, it could significantly contribute to economic growth if products are successfully commercialized. However, to date, relatively few products have reached the market owing to a variety of barriers, including a lack of funding and regulatory hurdles. The present study analyzes industry perceptions of the barriers to commercialization that currently impede the success of the regenerative medicine industry in the UK. MATERIALS & METHODS: The analysis is based on 20 interviews with leading industrialists in the field. RESULTS: The study revealed that scientific research in regenerative medicine is thriving in the UK. Unfortunately, lack of access to capital, regulatory hurdles, lack of clinical evidence leading to problems with reimbursement, as well as the culture of the NHS do not provide a good environment for the commercialization of regenerative medicine products. CONCLUSION: Policy interventions, including increased translational government funding, a change in NHS and NICE organization and policies, and regulatory clarity, would likely improve the general outcomes for the regenerative medicine industry in the UK. |
| | |
Authors:
|
Anke C Plagnol; Emma Rowley; Paul Martin; Finbarr Livesey |
Related Documents
:
|
20602344 - Linking a pharmaceutical claims database with a birth defects registry to investigate b... 19744294 - The impact of pharmaceutical cost containment policies on the range of medicines availa... 1604434 - Does the philosophy of medicine exist? 21391834 - Antimutagenic activity of two medicinal phytoextracts in somatic cells of drosophila me... 18438694 - Hotline update of clinical trials and registries presented at the german cardiac societ... 22238034 - Integrating perioperative information from divergent sources. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Regenerative medicine Volume: 4 ISSN: 1746-076X ISO Abbreviation: - Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-07-07 Completed Date: 2009-10-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278116 Medline TA: Regen Med Country: England |
Other Details:
|
Languages: eng Pagination: 549-59 Citation Subset: IM |
Affiliation:
|
Faculty of Politics, Psychology, Sociology & International Studies, University of Cambridge, Cambridge, CB2 3RQ, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Commerce* Great Britain Interviews as Topic Regenerative Medicine / economics*, legislation & jurisprudence* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of oxygen concentration, culture format and donor variability on in vitro chondrogenesis of h...
Next Document: Role of bioinspired polymers in determination of pluripotent stem cell fate.